Teleflex Acquires Innovative Technology for Laryngeal Masks and other Airway Management Devices


Teleflex Acquires Innovative Technology for Laryngeal Masks and other Airway Management Devices

LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYS: TFX) , a leading global provider of medical devices for critical care and surgery, today announced it has acquired the assets of Ultimate Medical and its affiliates. Ultimate Medical is a leading supplier and innovator of airway management devices with a portfolio of patented products and a full range of laryngeal mask airways.

Ultimate Medical developed the Cuff PilotTM, the world's first integrated cuff pressure indicator for single-use airway management devices. This novel technology is a single-use device and it provides constant inside-the-cuff pressure indication, allowing for at-a-glance clinical assessments.

The Cuff Pilot technology is currently used with Ultimate Medical's portfolio of laryngeal masks and has potential application for use with Teleflex's market leading brand of LMATMlaryngeal masks.

Teleflex has had a development partnership with Ultimate Medical since April 2010 related to the integration of cuff pressure technology into some products and currently distributes Ultimate's portfolio of laryngeal masks in select international markets.

In addition to the Cuff Pilot technology, the acquisition of Ultimate Medical further supports Teleflex's strategy to grow global supraglottic airway procedural usage by expanding their LMATM portfolio to include a full range of silicone laryngeal masks and other complimentary products. The transaction also brings innovative technologies and intellectual property that is expected to bring value to Teleflex outside of the airway management device portfolio.

"We consider the acquisition of Ultimate Medical to be a perfect match," said Liam Kelly, Executive Vice President, President, International. Added Kelly, "The acquisition of Ultimate Medical was a logical step after we acquired The Laryngeal Mask Company and its affiliates last year. This acquisition provides Teleflex with additional innovative, and cost-effective, airway management options for our customers and underscores our commitment to leadership in airway management medical devices."

The financial terms of the acquisition were not disclosed.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,700 people worldwide and serves healthcare providers in more than 140 countries. For additional information about Teleflex please refer to

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations

KEYWORDS: United States North America Pennsylvania


The article Teleflex Acquires Innovative Technology for Laryngeal Masks and other Airway Management Devices originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.